About this trial
To compare serum STN (Neuraminic acid-N-acetylgalactose)antigen concentrations in patients undergoing cesarean section and to study the factors associated with amniotic fluid entry.Compare the serum complement C4 concentration in patients in the amniotic fluid admission group with those in the non-admission group to study whether amniotic fluid admission triggers the body's immune response.To record the patients' blood pressure, heart rate, blood oxygen, and the occurrence of related symptoms and adverse reactions at the time of admission, at the time of blood collection, at the time of discharge from the room, and at the time of the occurrence of haemodynamic changes.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Approved consent and informed consent of the patient by the Ethics Committee of the Second Hospital of Shanxi Medical University;
ASA classification of I-III;
Age 20-50 years old;
No previous history of psychiatric diseases or psychotropic drugs;
Disqualifiers
Suffer from diseases of the cardiorespiratory system;
Those with communication difficulties who were unable to complete the screening questionnaire;
Trial population
Patients in the Second Hospital of Shanxi Medical University from May 2025 to November 2025
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
Enzyme-linked immunosorbent assay
Diagnostic testSerum STN and C4 levels were detected
Treatment groups
Trial outcomes
Primary outcomes
STN
Serum STN levels
C4
Serum C4 levels
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: